NADAC acquisition cost data for PARICALCITOL 1 MCG CAPSULE. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 49483068703 | $1.00 | 2022-12-21 | Rx |
| 65862093630 | $1.00 | 2022-12-21 | Rx |
| 68382033006 | $1.00 | 2022-12-21 | Rx |
| 69452014513 | $1.00 | 2022-12-21 | Rx |
| 49483068703 | $1.00 | 2022-12-21 | Rx |
| 65862093630 | $1.00 | 2022-12-21 | Rx |
| 68382033006 | $1.00 | 2022-12-21 | Rx |
| 69452014513 | $1.00 | 2022-12-21 | Rx |
Generic: Paricalcitol | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $9.5M | 53,375 | 11,225 | $4.53 |
| 2020 | $7.2M | 43,573 | 9,348 | $3.99 |
| 2021 | $5.5M | 35,479 | 8,202 | $3.55 |
| 2022 | $5.4M | 31,380 | 7,422 | $3.87 |
| 2023 | $4.5M | 28,839 | 6,778 | $3.49 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.